Drug Information

Drug General Information
Drug ID
D05NDN
Former ID
DNC000177
Drug Name
Alovudine
Drug Type
Small molecular drug
Indication Breast cancer [ICD9: 174, 175; ICD10:C50] Phase 2 [524903]
Structure
Download
2D MOL

3D MOL
Formula
C10H13FN2O4
Canonical SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F
InChI
1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1
InChIKey
UXCAQJAQSWSNPQ-XLPZGREQSA-N
CAS Number
CAS 25526-93-6
PubChem Compound ID
33039
PubChem Substance ID
595893, 8172954, 12014132, 14774145, 15221019, 17396987, 24862180, 34674983, 50054706, 50618601, 57311462, 68536877, 85202976, 91693945, 99299689, 103321186, 104023306, 104315122, 124343161, 126665390, 129433032, 134224699, 134339685, 134996084, 137156948, 137240496, 142354881, 144205929, 152057204, 162239272, 164839118, 170466324, 179150230, 198987252, 223395142, 223666099, 223725084, 224923940, 226501917, 249771531, 252543093
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Modulator
References
Ref 524903ClinicalTrials.gov (NCT02232581) Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.